New! Sign up for our email newsletter on Substack.

AMI: The scale of the problem

Barcelona, Spain, 1 September: Acute myocardial infarction (AMI) remains one of the leading causes of death in the Western world, with prevalence predicted to increase dramatically in developing countries, especially India and China. Around 40-50% of AMIs are the result of a persistent, complete thrombotic occlusion of a coronary artery. In such cases fast reopening of the infarct vessel is the primary goal of treatment.

This “reperfusion” therapy has been shown to save lives, especially when applied with 2-3 hours after the onset of infarction. Recanalisation of the infarct vessel can be obtained by administering thrombolytic agents (to dissolve the occlusive thrombus) or by performing a mechanical recanalisation followed by angioplasty of the culprit lesion (primary percutaneous intervention, PCI).

Primary PCI can open significantly more vessels than thrombolytic therapy, and therefore save more lives, but it can only be performed in facilities with a cath lab and an experienced team on stand-by.

Getting patients with an AMI to a PCI centre in the shortest possible time is a major challenge which requires a close collaboration between cardiologists of different hospitals and the emergency medical system. The ESC and health authorities in different countries are currently taking many initiatives to set-up these networks.


Did this article help you?

If you found this piece useful, please consider supporting our work with a small, one-time or monthly donation. Your contribution enables us to continue bringing you accurate, thought-provoking science and medical news that you can trust. Independent reporting takes time, effort, and resources, and your support makes it possible for us to keep exploring the stories that matter to you. Together, we can ensure that important discoveries and developments reach the people who need them most.